Marie-Yvonne Landel-Meunier
Director/Board Member at TRANSGENE
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lucie Larguier | F | - | 8 years | |
| Alessandro Riva | M | 63 | 2 years | |
| Philippe Archinard | M | 63 | 20 years | |
| François-Henri Reynaud | M | - | 7 years | |
| Jean-Yves Blay | M | 61 | 2 years | |
| Carol Stuckley | F | 68 | 1 years | |
| Caroline Courme | F | - | 8 years | |
| Ismaël Nujurally | M | 67 | 5 years | |
| Maya Said | M | 47 | 7 years | |
| Marc Bouillet | M | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| John Felitti | M | 54 | 8 years | |
| Marie-Christine Ouillade | F | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Philippe Petrou | M | 61 | 5 years | |
| Benoît Habert | M | 59 | 24 years | |
| Marc Bazin | M | - |
HepatoChem, Inc.
 HepatoChem, Inc. Pharmaceuticals: MajorHealth Technology HepatoChem, Inc. provides pharmaceutical and biotech services. Its services include metabolite synthesis, chemical diversity, chemistry kits, metabolite structure elucidation, metabolic stability study and analytical services. The company was founded in 2008 by Marc Bazin and John T. Groves and is headquartered in Beverly, MA. | 16 years |
| Marie-Christine Belleville | F | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Gaëlle Stadtler | F | 40 | 3 years | |
| Christophe Ancel | M | 60 | - | |
| Nathalie Triclin-Conseil | F | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Sandrine Flory | F | - | 3 years | |
| Jean-Luc Bélingard | M | 74 | 11 years | |
| Maud Brandely | M | 70 | 8 years | |
| Alexandre Lemoalle | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 9 years |
| Jean-Pierre Lamorte | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 17 years |
| Claude Le Pen | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Alain Mérieux | M | 85 | 33 years | |
| Eric Quéméneur | M | 60 | 10 years | |
| Nathalie Vazquez | F | - | 5 years | |
| Laurence Tiennot-Herment | F | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 15 years |
| Frédéric Revah | M | 62 |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 14 years |
| Jean-Marie Vallet | M | - |
HepatoChem, Inc.
HepatoChem, Inc. Pharmaceuticals: MajorHealth Technology HepatoChem, Inc. provides pharmaceutical and biotech services. Its services include metabolite synthesis, chemical diversity, chemistry kits, metabolite structure elucidation, metabolic stability study and analytical services. The company was founded in 2008 by Marc Bazin and John T. Groves and is headquartered in Beverly, MA. | - |
| Claude Allary | M | 69 |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| James Wentworth | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dominique Petit | M | 57 | 9 years | |
| Hedi Brahim | M | 43 | 4 years | |
| Alain Coudray | M | - | - | |
| Michael DeMane | M | 67 | 5 years | |
| David Solomon | M | 63 | 4 years | |
| Elvire Huisse | F | - | 1 years | |
| Yves Vignancour | M | 59 | 2 years | |
| Eric Pottier | M | - | 3 years | |
| Anne Reiser | F | 62 | 1 years | |
| Philippe Chêne | M | 65 | 3 years | |
| Jean-François Labbé | M | 73 | 8 years | |
| Damian Marron | M | 62 | 2 years | |
| Thierry Laugel | M | 57 | 1 years | |
| Laurence Espinasse | F | - | - | |
| Stéphanie Robert | F | - | 3 years | |
| Sjors Hermans | M | - | 2 years | |
| Sven Claes | M | - | 2 years | |
| GOAD FRED | M | 79 | 3 years | |
| Li Zhou | M | - | 2 years | |
| Steven Bloom | M | 63 | - | |
| Maud Bouvier | M | 46 | - | |
| Arnaud Foussat | M | - | 13 years | |
| Nathalie Belmonte | M | 49 | 11 years | |
| Jean-Philippe Del | M | 44 | 19 years | |
| Vanessa Malier | F | 51 | - | |
| Laurent Arthaud | M | 61 | 6 years | |
| Gérard Vaillant | M | 82 | 6 years | |
| Thierry Bertrand Lambert | M | - | 2 years | |
| Stéphane Boissel | M | 56 | - | |
| Catherine Mathis | M | 58 | - | |
| Dominique Takizawa | F | 67 | 19 years | |
| Arnaud Dubarry | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 63 | 96.92% |
| United States | 2 | 3.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marie-Yvonne Landel-Meunier
- Personal Network